Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine

Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine

Radioiodine therapy of metastatic differentiated thyroid cancer is a highly effective method of treatment which makes it possible to achieve the complete cure of the majority of patients, however in some cases radioiodine refractory type develops, it leads to significant deterioration in overall and...

Full description

Bibliographic Details
Main Authors:	E. B. Vasil’eva, A. V. Vazhenin, T. M. Geliashvili, N. V. Fadeeva, A. V. Garev, A. O. Guz’
Format:	Article
Language:	Russian
Published:	ABV-press 2018-04-01
Series:	Опухоли головы и шеи
Subjects:	differentiated thyroid cancer radioiodine therapy sorafenib
Online Access:	https://ogsh.abvpress.ru/jour/article/view/320

Similar Items

CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

The use of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in patients with differentiated thyroid cancer after initial treatment
by: T. M. Geliashvili, et al.
Published: (2017-04-01)

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
by: Aleksandra Kukulska, et al.
Published: (2020-08-01)

Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness
by: E. V. Borodavina, et al.
Published: (2024-08-01)

Guidelines for radioiodine therapy in differentiated thyroid cancer and post-therapeutic follow-up
by: A. Yu. Shurinov, et al.
Published: (2024-06-01)

Neoadjuvant target therapy of differentiated thyroid cancer (clinical observation)
by: P. A. Isaev, et al.
Published: (2017-04-01)

Radioiodine treatment in female survivors of pediatric differentiated thyroid carcinoma does not affect future pregnancy rates
by: Marise Codeco de Andrade Barreto, et al.
Published: (2024-10-01)

Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers
by: Abdul Rehman Syed, et al.
Published: (2024-05-01)

Value of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in staging of patients with differentiated thyroid cancer after thyroidectomy during the first course of radioiodine therapy
by: T. M. Geliashvili, et al.
Published: (2021-01-01)

A Mathematical Model of Thyroid Disease Response to Radiotherapy
by: Araceli Gago-Arias, et al.
Published: (2021-09-01)

Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
by: M. S. Brose, et al.
Published: (2018-07-01)

Effect of recombinant human thyroid stimulating hormone on radioactive iodine uptake by thyroid carcinoma in dogs
by: Stephanie Scheemaeker, et al.
Published: (2024-07-01)

Errors in the treatment of highly differentiated thyroid cancer as a multidisciplinary problem
by: N. I. Volkova, et al.
Published: (2021-07-01)

Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
by: Maaike Dotinga, et al.
Published: (2022-12-01)

Prognostic factors for postoperative papillary thyroid cancer with unexplained elevated Tg: A retrospective study
by: Chenghui Lu, et al.
Published: (2024-03-01)

Historical aspects and modern concepts in the treatment of patients with differentiated thyroid cancer, refractory to radioactive iodine therapy
by: E. V. Borodavina, et al.
Published: (2022-02-01)

Diagnostic features of lung metastases differentiated thyroid cancer
by: T. M. Geliashvili, et al.
Published: (2016-01-01)

Success Rate in Preparation of Patients with Thyroid Cancer for I-131 Total Body Scan by 3-Week Discontinuation of Thyroxine
by: Chetsadaporn Promteangtrong, et al.
Published: (2020-07-01)

Simplified Assessment of Radioiodine Biokinetics for Thyroid Cancer Patients: A Practical Approach Using Continuous External Radiation Monitoring
by: Yao-Kuang Tsai, et al.
Published: (2024-05-01)

Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation
by: E. V. Borodavina, et al.
Published: (2020-04-01)

Correlation between remnant thyroid gland I-131 uptake and serum thyroglobulin levels: can we rely on I-131 whole body scans?
by: Sang Hyun Hwang, et al.
Published: (2024-01-01)

RADIOIODINE THERAPY OF PAPILLARY THYROID CANCER, COMPLICATED BY A RADIAL MYELITIS. CLINICAL CASE
by: L. M. Farkhutdinova
Published: (2018-06-01)

Ultrasound Assessment of Autonomous Thyroid Nodules before and after Radioiodine Therapy Using Thyroid Imaging Reporting and Data System (TIRADS)
by: Simone Agnes Schenke, et al.
Published: (2020-12-01)

Algorithm of stepwise medical rehabilitation of patients with differentiated thyroid cancer
by: T. I. Grushina, et al.
Published: (2021-04-01)

Advances in molecular mechanisms of iodine-131 therapy resistance in thyroid carcinoma
by: LIU Shiqi, et al.
Published: (2024-07-01)

Prolonged duration of response in lenvatinib responders with thyroid cancer (Russian translation)
by: A. G. Gianoukakis, et al.
Published: (2018-11-01)

Rapid predictive dosimetry for Second Strike prescription based on whole body radioiodine kinetics in differentiated thyroid cancer
by: Yung Hsiang Kao
Published: (2024-01-01)

The potential association of peripheral inflammatory biomarkers in patients with papillary thyroid cancer before radioiodine therapy to clinical outcomes
by: Jingjia Cao, et al.
Published: (2023-12-01)

Retrospective Analysis of the Development of Human Thyroglobulin during Pregnancy in Patients with Treated Non-Recurrent Differentiated Thyroid Cancer
by: Justus Baumgarten, et al.
Published: (2022-05-01)

Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland
by: Henryk Zulewski, et al.
Published: (2019-01-01)

Differentiated thyroid carcinoma: what the nonspecialists needs to know
by: Ana O. Hoff, et al.
Published: (2024-06-01)

Initial results of the INSPIRE clinical trial—investigating radiation dosimetry for differentiated thyroid cancer patients
by: Jan Taprogge, et al.
Published: (2023-05-01)

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
by: Massimiliano Pacilio, et al.
Published: (2022-07-01)

Normal reference values for Tc-99m pertechnetate thyroid uptake in northern Iranian population: A single-center experience
by: Amir Gholami, et al.
Published: (2024-05-01)

<sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer
by: T. M. Geliashvili, et al.
Published: (2020-02-01)

Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma
by: Omar Elghawy, et al.
Published: (2024-11-01)

Strongly Radioiodine-Positive Pancreatic Adenocarcinoma Mimicking Metastasis of Differentiated Thyroid Cancer
by: Florian Rosar, et al.
Published: (2022-08-01)

Concomitant lithium increases radioiodine uptake and absorbed doses per administered activity in graves’ disease: comparison of conventional versus lithium-augmented radioiodine therapy
by: Fadi Khreish, et al.
Published: (2024-04-01)

Guidelines for the Diagnosis, Treatment, and Management of Iodine Refractory Differentiated Thyroid Cancer(2023 edition)
by: WEN Qiang, et al.
Published: (2023-11-01)

PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION
by: M. Yu. Frolov, et al.
Published: (2016-04-01)